InvestorsHub Logo

Northrock

11/24/17 2:03 PM

#81 RE: Marujido #79

Marujido, cheers and happy Thanksgiving, GROW killed it today, #2 on the entire big board :)

off topic but

check out GOVX

tiny gem at $5M mcap at .075, has a $50M CDC grant and $7.8M HiV vaccine network production deal

GeoVax's product pipeline is based on its Modified Vaccine Ankara (MVA)
Virus-Like Particle (VLP) vaccine platform. This platform - mimicking a natural infection and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control target infections.

Successfully completed phase 1 and phase 2a human clinical trials, which were conducted by the HiV Vaccine Trials Network (HVTN) - that has a $7.8M dollar contract with GOVX for production.

it's ZiKA vaccine 100% eliminated the virus whereas the non-vaccinated animals died in 7days

moving day average lines are all rising (above 50mda, 100mda, 200mda in the 1year view)

nice timely dip here